Lilly funds second factory line for inhaled insulin

January 8, 2007
Eli Lilly and Co. has agreed to fund a second manufacturing line at an Alkeres Inc. plant to make its Inhaled Insulin System powder. Lilly’s system, to be marketed as an alternative for types 1 and 2 diabetes, is in phase 3 clinical trials.

The deal also makes Cambridge, Mass.-based Alkeres the exclusive manufacturer of the drug. Terms were not disclosed.
Source: XMLFULL/XMLFull296.xml

Recent Articles by IBJ Staff

Comments powered by Disqus